Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized comparison of sequential vs concomitant therapy for Helicobacter pylori eradication
2009-016517-14Phase 4Active
- Sponsor
- Dr. Javier Pérez Gisbert
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection, functional dyspepsia (FD) and Peptic ulcer disease (PUD) (2 arms), sponsored by Dr. Javier Pérez Gisbert. Primary endpoint: Helicobacter pylori eradication rate (intention-to-treat). Started Aug 2010; status: active.
02
Drugs
omeprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infectionfunctional dyspepsia (FD)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on 2009-016517-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016517-14.